Rafael Puya-Jimenez
Cordoba, AN, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Comparison of phenotype, comorbidities, therapy and adverse events between psoriatic patients with and without psoriatic arthritis. Biobadaderm registry.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: November 03, 2016
Infections in Moderate to Severe Psoriasis Patients Treated with Biological Drugs Compared to Classic Systemic Drugs: Findings from the BIOBADADERM Registry.
Journal: The Journal of investigative dermatology
Published: May 06, 2016
Management of Biologic Therapy in Moderate to Severe Psoriasis in Surgical Patients: Data From the Spanish Biobadaderm Registry.
Journal: Actas dermo-sifiliograficas
Published: March 19, 2016
Survival of classic and biological systemic drugs in psoriasis: results of the BIOBADADERM registry and critical analysis.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: December 23, 2015
Survival rate of etanercept for psoriasis in real life: a multicentre observational study.
Journal: European journal of dermatology : EJD
Published: August 14, 2014
Paraneoplastic Acral Vascular Syndrome.
Journal: Actas dermo-sifiliograficas
Published: August 01, 2014
Immune-mediated inflammatory diseases and other comorbidities in patients with psoriasis: baseline characteristics of patients in the AQUILES study.
Journal: Actas dermo-sifiliograficas
Published: May 07, 2014
Safety of classic and biologic systemic therapies for the treatment of psoriasis in elderly: an observational study from national BIOBADADERM registry.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: March 12, 2014
Risk of adverse events in psoriasis patients receiving classic systemic drugs and biologics in a 5-year observational study of clinical practice: 2008-2013 results of the Biobadaderm registry.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: December 18, 2013
Factors influencing seasonal patterns of relapse in anti-TNF psoriatic responders after temporary drug discontinuation.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: May 09, 2013
Body mass index in patients with moderate-to-severe psoriasis in Spain and its impact as an independent risk factor for therapy withdrawal: results of the Biobadaderm Registry.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: February 21, 2013
Last Updated: 09/26/2026